Exact Mass: 366.1611
Exact Mass Matches: 366.1611
Found 442 metabolites which its exact mass value is equals to given mass value 366.1611
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
dehydrocorydalin
Dehydrocorydaline is an alkaloid. Dehydrocorydaline is a natural product found in Corydalis turtschaninovii, Corydalis nobilis, and other organisms with data available. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
Diacetoxyscirpenol
Diacetoxyscirpenol is a constituent of Fusarium species Mycotoxin D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins Constituent of Fusarium subspecies Mycotoxin C784 - Protein Synthesis Inhibitor D000970 - Antineoplastic Agents
Rilpivirine
Rilpivirine belongs to the class of organic compounds known as nitrotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and at least 1 nitro group. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
4-Acetyl-2-prenylphenol glucoside
4-Acetyl-2-prenylphenol glucoside is found in herbs and spices. 4-Acetyl-2-prenylphenol glucoside is a constituent of Helichrysum italicum (curry plant). Constituent of Helichrysum italicum (curry plant). 4-Acetyl-2-prenylphenol glucoside is found in tea and herbs and spices.
Secoeremopetasitolide A
Secoeremopetasitolide A is found in green vegetables. Secoeremopetasitolide A is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot). Secoeremopetasitolide A is found in green vegetables.
1-[(1R,2R,3S,4S)-3-Hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea
(E)-4-(4-(4-(2-Cyanovinyl)-2,6-dimethylphenylamino)pyrimidin-2-ylamino)benzonitrile
5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine
Britannin
Britannin, isolated from Inula aucheriana, is a sesquiterpene lactone. Britannin induces apoptosis and autophagy by activating AMPK regulated by ROS in liver cancer cells. Britannin has anti-proliferative and anti-inflammatory activities[1][2][3]. Britannin, isolated from Inula aucheriana, is a sesquiterpene lactone. Britannin induces apoptosis and autophagy by activating AMPK regulated by ROS in liver cancer cells. Britannin has anti-proliferative and anti-inflammatory activities[1][2][3].
Dehydrocorydaline
Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
GLIBORNURIDE
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
(1alpha,2alpha,3beta,4beta,6beta,8alpha,9alpha)-1,2,3,4,6,8,9,13,14-Nonahydroxydihydro-beta-agarofuran|Euonyminol|Euonyminol?
(+)-2-(1-hydroxy-4,4-dimethoxycyclohexyl)ethyl caffeate|2-(1-hydroxy-4,4-dimethoxycyclohexyl)ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate|mairine D
(1R,4S,5S,6S,7S,10R)-1-hydroxy-4,15-diacetoxyeudesm-11(13)-en-6,12-olide
methyl (1S,10R,12S,19S)-12-ethenyl-4-hydroxy-9-oxo-8,16-diazapentacyclo[10.6.1.0^{1,10.0^{2,7.0^{16,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
8alpha-hydroxy-10beta,11alpha-diacetoxyslov-3-enolide
3alpha,9beta-diacetoxy-1beta,10-epoxy-germacr-5(4)-en-6beta,12-olide|beibersteneolide-a
8alpha-isobutyryloxy-11(betaH),13-dihydro-10-epi-tanaparthin-alpha-peroxide
1beta,6alpha-diacetoxy-4alpha-hydroxyeudesm-11-en-8alpha,12-olide
3-butenyl 6-O-(alpha-L-arabinopyranosyl)-beta-D-glucopyranoside
2-(3,4-dihydroxyphenyl)ethyl [(2,6-dimethoxy-3-ethylidene)tetrahydropyran-4-yl]acetate|3,4-DHPEA-DETA
3,4beta-dihydrosamaderine C|3,4??-Dihydrosamaderine C
19(E)-18-demethoxygardfloramine
A natural product found in Gardneria ovata.
3,9-diacetoxy-1-hydroxy-6beta,7alpha,11H-germacra-4,10(14)-dien-12,6alpha-olide
10-hydroxyisovallesiachotamine|methyl (2S,12bS)-1,2,6,7,12,12b-hexahydro-9-hydroxy-2-[(2E)-1-oxobut-2-en-2-yl]indolo[2,3-a]quinolizine-3-carboxylate
4beta,10alpha-dihydroxy-3-oxo-8beta-isobutyroyloxyguaia-11(13)-en-6,12-olide|4beta,10alpha-dihydroxy-3-oxo-8beta-isobutyrylguai-11(13)-en-6alpha,12-olide|7a,10a-dihydroxy-3-oxo-8b-isobutyryloxyguaia-11(13)-en-12,6a-olide|TD-14
5-dehydro-3-hydro-7beta-hydroxy-6-oxoeurycolactone E
3,15-Diacetoxyscirpen-4-ol|3,15-diacetoxyscirpenol
9alpha-hydroxy-seco-ratiferolide-5alpha-O-isobutyrate
(6S,7R,8S,11S)-8,14-diacetoxy-15-hydroxygermacra-1(10),4-dien-6,12-olide
12,16-Dihydroxystrychnine|3,12-dihydroxystrychnine|4,16-Dihydroxystrychnin
2beta-Hydroxy-2,3,11alpha,13-tetrahydrohelenalin-methacrylat
8alpha-O-(2,3-dihydroxyisobutyryl)-11beta,13-dihydrodesacylcynaropicrin
(1S,4R,5S,6S,7S,10R)-1,15-diacetoxy-4-hydroxyeudesm-11(13)-en-6,12-olide
(E)-1-(3-chloro-6-(3,7-dimethylocta-2,6-dienyloxy)-2,4-dihydroxyphenyl)butan-1-one
Dehydrocorydaline
Annotation level-1 Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
Ala Gly Gly Tyr
Ala Gly Tyr Gly
Ala Tyr Gly Gly
Phe Gly Gly Ser
Phe Gly Ser Gly
Phe Ser Gly Gly
Gly Ala Gly Tyr
Gly Ala Tyr Gly
Gly Phe Gly Ser
Gly Phe Ser Gly
Gly Gly Ala Tyr
Gly Gly Phe Ser
Gly Gly His Pro
Gly Gly Pro His
Gly Gly Ser Phe
Gly Gly Tyr Ala
Gly His Gly Pro
Gly His Pro Gly
Gly Pro Gly His
Gly Pro His Gly
Gly Ser Phe Gly
Gly Ser Gly Phe
Gly Tyr Ala Gly
Gly Tyr Gly Ala
His Gly Gly Pro
His Gly Pro Gly
His Pro Gly Gly
Pro Gly Gly His
Pro Gly His Gly
Pro His Gly Gly
Ser Phe Gly Gly
Ser Gly Phe Gly
Ser Gly Gly Phe
Tyr Ala Gly Gly
Tyr Gly Ala Gly
Tyr Gly Gly Ala
4-Acetyl-2-prenylphenol glucoside
Secoeremopetasitolide A
[8-[(4-amino-2-nitrophenyl)azo]-7-hydroxy-2-naphthyl]trimethylammonium
methyl 4-chloro-1-[tris(propan-2-yl)silyl]-1H-pyrrolo[2,3-b]pyridine-5-carboxylate
Trihydridobis(pentaMethylcyclopentadienyl)niobiuM(V)
3,4:5,6-Di-O-isopropylidene-D-glucose diethyl mercaptal
ethyl 3-undecylthieno[3,2-b]thiophene-2-carboxylate
3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-
Urea, 1-(2-hydroxy-3-bornyl)-3-(p-tolylsulfonyl)-, (1R,2R,3S,4S)-
8-(4-aminophenyl)-5-methyl-N-propyl-5H-[1,3]dioxolo[4,5-g]phthalazine-6-carboxamide
SYM2206 is a potent and non-competitive AMPA receptor antagonist, with an IC50 of 1.6 μM. SYM2206 blocks Nav1.6-mediated persistent currents[1][2].
[amino-[2-[(6-carbamimidoyl-1H-benzimidazol-2-yl)-dihydroxymethyl]-3H-benzimidazol-1-ium-5-yl]methylidene]azanium
Rilpivirine
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
[(1R,2R,10R)-10-acetyloxy-4-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
(1R,2R,5R,6R,8R,9S,10R,11R,12S)-6,12-dihydroxy-6-(hydroxymethyl)-11-methyl-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
inuchinenolide C
A sesquiterpene lactone that is decahydroazuleno[6,5-b]furan-2(3H)-one substituted by acetyloxy groups at positions 5 and 7, a hydroxy group at position 4, methyl groups at positions 4a and 8 and a methylidene group at position 3. It has been isolated from the aerial parts of Inula hupehensis.
1-hydroxy-5-nitro-N-(2-phenylethyl)-4-spiro[benzimidazole-2,1-cyclohexane]imine
1-[[3-(9-Carbazolyl)-1-oxopropyl]amino]-3-(2-methylprop-2-enyl)thiourea
4-(1H-indol-3-yl)butanoic acid [2-(3-methoxyanilino)-2-oxoethyl] ester
4-(1,3-dioxo-2-isoindolyl)-N-[2-(4-methoxyphenyl)ethyl]butanamide
4-(3-Methoxyanilino)-2-methyl-5-oxo-1-phenyl-2-pyrrolecarboxylic acid ethyl ester
N-[(8-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-(2-oxolanylmethyl)-2-furancarboxamide
1-Butyl-3-[[2-oxo-1-(phenylmethyl)-3-indolylidene]amino]thiourea
N-[6-ethyl-6-methyl-2-(methylthio)-5,8-dihydropyrano[4,5]thieno[1,2-c]pyrimidin-4-yl]-N,N-dimethylethane-1,2-diamine
2-(2-amino-1-benzimidazolyl)-N-(phenylmethyl)-4-quinazolinamine
N-ethyl-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
N-ethyl-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
1-[(2S,3R)-2-(hydroxymethyl)-6-[oxo(2-pyrazinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[[4-[(S)-(3-chlorophenyl)-imidazol-1-ylmethyl]phenyl]methyl]piperazine
[2-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] propanoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] butanoate
2-(Phenylethynyl)-2-(para-tolyl)-hexamethyltrisilane
1-(Meta-tolyl)-1,2-bis(trimethylsilyl)-1-silaindene
2-Ethyl-1,1,2,3,3-pentamethyl-4,5-diphenyl-1,2,3-trisilacyclopenta-4-ene
1-(2,2,2-Trimethyl-1-phenyl-1-(o-tolyl)disilanyl)-2-(trimethylsilyl)acetylene
COTI-2
COTI-2, an anti-cancer agent with low toxicity, is an orally available third generation activator of p53 mutant forms. COTI-2 acts both by reactivating mutant p53 and inhibiting the PI3K/AKT/mTOR pathway. COTI-2 induces apoptosis in multiple human tumor cell lines. COTI-2 exhibits antitumor activity in HNSCC through p53-dependent and -independent mechanisms. COTI-2 converts mutant p53 to wild-type conformation[1][2][3].
(2s)-2-[(1ar,1bs,3as,5r,7bs,9as)-1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-5-yl]-2-bromoethanol
(2s)-2-[(4s)-4-[(1r,2r,5s)-2-[(acetyloxy)methyl]-1-methyl-6-oxabicyclo[3.1.0]hexan-2-yl]-3-oxocyclopent-1-en-1-yl]-2-hydroxypropyl acetate
methyl (1r,9s,11s,14z,15s,17s,19r)-14-ethylidene-19-formyl-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
[4-(acetyloxy)-10-(hydroxymethyl)-3-methyl-2-oxo-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-yl]methyl acetate
(3s,3ar,4s,4ar,7r,7as,8r,9ar)-7-hydroxy-3,4a,8-trimethyl-2,5-dioxo-octahydro-3h-azuleno[6,5-b]furan-4-yl 2-(hydroxymethyl)prop-2-enoate
2-(3,4-dihydroxyphenyl)ethyl 2-[(2r,3e,4s,6r)-3-ethylidene-2,6-dimethoxyoxan-4-yl]acetate
(3ar,4as,5r,6r,7r,7as,8r,9ar)-5-(acetyloxy)-6-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl acetate
(3ar,4s,4ar,5s,7s,7as,8r,9as)-5-(acetyloxy)-4-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl acetate
(3as,4s,4ar,5s,7s,7as,8r,9as)-7-(acetyloxy)-5-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4-yl acetate
2-(3,4-dihydroxyphenyl)ethyl 2-(3-ethylidene-2,6-dimethoxyoxan-4-yl)acetate
(1s,4s,4ar,5r,8as)-5-(acetyloxy)-3,4-diformyl-4-hydroxy-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1h-naphthalen-1-yl acetate
methyl 5-(hydroxymethyl)-6-methyl-4-{9h-pyrido[3,4-b]indol-1-ylmethyl}-5,6-dihydro-4h-pyran-3-carboxylate
8-(acetyloxy)-5-hydroxy-5,8a-dimethyl-3-methylidene-2-oxo-octahydronaphtho[2,3-b]furan-4-yl acetate
4,8,9,12-tetrahydroxy-2,6,10,16-tetramethyl-14-oxatetracyclo[11.2.1.0²,¹¹.0⁵,¹⁰]hexadec-6-ene-3,15-dione
(3ar,4s,5r,6r,10r,11ar)-5,6-dihydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,10h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
2-(1-hydroxy-4,4-dimethoxycyclohexyl)ethyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(3ar,4s,6ar,8s,9r,9as,9bs)-8,9-dihydroxy-9-(hydroxymethyl)-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 2-methylpropanoate
6-butoxy-9,11-dihydroxy-10-methoxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxecine-2,8-dione
(1s,2r,3s,9r)-5-acetyl-4-hydroxy-8,8,16-trimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-4,11(18),12,14-tetraene-6,17-dione
methyl (1r,9s,11s,14e,15s,17s,19s)-14-ethylidene-19-formyl-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
2-{1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-5-yl}-2-bromoethanol
(1r,2s,4s,5r,7e,10s,11s,12r)-10-(acetyloxy)-4,8,12-trimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-5-yl acetate
2,7,15-trihydroxy-5-methoxy-11-methyl-10,19-dioxatricyclo[14.2.1.0³,⁸]nonadeca-3,5,7-trien-9-one
6-(acetyloxy)-5-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl acetate
[(3as,6s,6ar,9s,9as,9br)-9-(acetyloxy)-6a-hydroxy-6-methyl-3-methylidene-2-oxo-octahydroazuleno[4,5-b]furan-9a-yl]methyl acetate
3,8,9,12-tetrahydroxy-2,6,10,16-tetramethyl-14-oxatetracyclo[11.2.1.0²,¹¹.0⁵,¹⁰]hexadec-5-ene-4,15-dione
2-[(1r,2e,3s,12br)-3-ethyl-1-formyl-1h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-ylidene]-3-oxopropanoic acid
3-(4-hydroxy-3,5-dimethoxyphenyl)-n-[2-(1h-indol-3-yl)ethyl]prop-2-enimidic acid
(2r)-2-[(1as,1bs,5r,7as,7bs,9ar)-1a,5,7b-trimethyl-1h,1bh,2h,4h,6h,7h,7ah,8h,9h,9ah-cyclopropa[a]phenanthren-5-yl]-2-bromoethanol
[(3as,5ar,6r,9s,9as,9bs)-9-(acetyloxy)-6-hydroxy-5a-methyl-3-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-9-yl]methyl acetate
(2s,3r)-16-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁶.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-trien-15-one
methyl (1s,9z,12s,13z)-12-formyl-12-methyl-19-oxo-8,16-diazatetracyclo[14.2.1.0¹,⁹.0²,⁷]nonadeca-2,4,6,9,13-pentaene-10-carboxylate
(1r,2z,4r,8r,9r,11r)-1-hydroxy-2-(hydroxymethyl)-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylpropanoate
(1r,3s,3'r,6e,10r)-10-[(acetyloxy)methyl]-3',6-dimethyl-5-oxo-11-oxaspiro[bicyclo[8.1.0]undecane-3,2'-oxiran]-6-en-3'-ylmethyl acetate
4,5,9-trihydroxy-4a-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl 2-methylbut-2-enoate
3,4β-dihydrosamaderine c
{"Ingredient_id": "HBIN007327","Ingredient_name": "3,4\u03b2-dihydrosamaderine c","Alias": "NA","Ingredient_formula": "C19H26O7","Ingredient_Smile": "CC1CC(C(C2(C1CC(=O)C34C2C(C5C(C3C(=O)O5)(OC4)C)O)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5705","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-butenyl-6'-o-α-l-arabinopyranosyl-β-d-gluco-pyranoside
{"Ingredient_id": "HBIN008350","Ingredient_name": "3-butenyl-6'-o-\u03b1-l-arabinopyranosyl-\u03b2-d-gluco-pyranoside","Alias": "NA","Ingredient_formula": "C15H26O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2781","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4α,10α-dihydroxy-3-oxo-8β-isobutyryloxyguaia-11(13)-en-12,6α-olide
{"Ingredient_id": "HBIN010179","Ingredient_name": "4\u03b1,10\u03b1-dihydroxy-3-oxo-8\u03b2-isobutyryloxyguaia-11(13)-en-12,6\u03b1-olide","Alias": "NA","Ingredient_formula": "C19H26O7","Ingredient_Smile": "CC(C)C(=O)OC1CC(C2CC(=O)C(C2C3C1C(=C)C(=O)O3)(C)O)(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6063","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
anticancersesquiterpene pmv70p691-134
{"Ingredient_id": "HBIN016354","Ingredient_name": "anticancersesquiterpene pmv70p691-134","Alias": "NA","Ingredient_formula": "C19H26O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1438","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}